Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Late Breaking Poster Session - Late Breaking Poster Session
  • Late Breaking Poster Session
  • 1982-LB - MPC-Directed Insulin Sensitizer MSDC-0602K Combines with Tirzepatide to Maintain Muscle Mass/Function and Restructure Adipose Tissue [Board No. 1982]
  • Schedule
    Notes
  • Location IconPoster Hall (Hall F1)
    130
    Set Timezone
M.Abu-farha: None. J.Abubaker: None. F.Almulla: None. M.Abdul-ghani: None. L.Norton: None. R.A.Defronzo: Advisory Panel; ; AstraZeneca, Boehringer-Ingelheim, Corcept Therapeutics, Novo Nordisk, Research Support; ; AstraZeneca, Boehringer-Ingelheim, 89bio, Inc, Amgen Inc, Speaker's Bureau; ; AstraZeneca, Corcept Therapeutics. J.R.Colca: Stock/Shareholder; ; Cirius Therapeutics, Inc. K.S.Mccommis: Research Support; ; Cirius Therapeutics, Inc.
Type
Main Session